Domains targeting keyword lung tumors

Keyword lung tumors was used in the provided list of websites.

Number of websites/domains displayed: 5
Results found: 5

Websites discovered:

Home - RMES - Radon Measurement & Elimination Services

http://pageoverview.com/website-report/rmeswi.com

Radon Measurement & Elimination Services for Southeastern Wisconsin.

Expected expiration: February 14th in 2019
Creation date: February 14th in 2006
Renew date: February 15th in 2018

CTisus | CT Scan, Protocols, Lectures, Images | Advanced CT Scan Imaging

http://pageoverview.com/website-report/ctisus.com

CT Imaging and Medical Imaging Protocols, Case Studies, Images, Lectures, Podcasts, Vodcasts, 3D CTA cases and Atlas, CT Scanning.|CTisus

Expected expiration: February 5th in 2019
Creation date: February 5th in 1999
Renew date: December 16th in 2016
Google Analytics: 37422858-1
Google Plus Account: 101394411661274866911

http://pageoverview.com/website-report/galilmedical.com

Global leader of innovative cryotherapy solutions. Delivering a new era of cryotherapy for minimally invasive, targeted cryosurgical ablation.

Expected expiration: April 27th in 2020
Creation date: April 27th in 2000
Renew date: August 29th in 2016
Google Analytics: 45941207-1

Home | CyberKnife

http://pageoverview.com/website-report/cyberknife.com

The CyberKnife System is a non-invasive1 treatment for cancerous and non-cancerous tumors and other conditions where radiation therapy is indicated. It is used to treat conditions throughout the body, including tumors of the prostate, lung, brain, spine, head and neck, liver, pancreas, kidney, and certain gynecologic indications, and can be an alternative to surgery or for some patients who have inoperable or surgically complex tumors.

Expected expiration: March 6th in 2018
Creation date: March 6th in 1999
Renew date: February 28th in 2017
Google Analytics: 57269326-1

Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)

http://pageoverview.com/website-report/cyramza.com

CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).

Expected expiration: October 5th in 2018
Creation date: October 5th in 2011
Renew date: October 1st in 2017